ICON EBITDA Margin 2010-2025 | ICLR
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for ICON (ICLR) over the last 10 years. The current EBITDA margin for ICON as of March 31, 2025 is .
| ICON EBITDA Margin Historical Data |
| Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
| 2025-03-31 |
$8.19B |
$1.47B |
17.91% |
| 2024-12-31 |
$8.28B |
$1.59B |
19.15% |
| 2024-09-30 |
$8.31B |
$1.61B |
19.40% |
| 2024-06-30 |
$8.33B |
$1.64B |
19.67% |
| 2024-03-31 |
$8.23B |
$1.62B |
19.62% |
| 2023-12-31 |
$8.12B |
$1.54B |
18.99% |
| 2023-09-30 |
$8.02B |
$1.48B |
18.49% |
| 2023-06-30 |
$7.90B |
$1.45B |
18.33% |
| 2023-03-31 |
$7.82B |
$1.42B |
18.11% |
| 2022-12-31 |
$7.74B |
$1.37B |
17.65% |
| 2022-09-30 |
$7.66B |
$1.30B |
17.01% |
| 2022-06-30 |
$7.59B |
$1.06B |
14.02% |
| 2022-03-31 |
$6.52B |
$0.87B |
13.34% |
| 2021-12-31 |
$5.48B |
$0.69B |
12.66% |
| 2021-09-30 |
$4.36B |
$0.55B |
12.56% |
| 2021-06-30 |
$3.19B |
$0.51B |
16.05% |
| 2021-03-31 |
$2.94B |
$0.47B |
16.02% |
| 2020-12-31 |
$2.80B |
$0.46B |
16.37% |
| 2020-09-30 |
$2.76B |
$0.46B |
16.65% |
| 2020-06-30 |
$2.77B |
$0.48B |
17.40% |
| 2020-03-31 |
$2.85B |
$0.52B |
18.42% |
| 2019-12-31 |
$2.81B |
$0.53B |
18.75% |
| 2019-09-30 |
$2.76B |
$0.50B |
18.27% |
| 2019-06-30 |
$2.70B |
$0.49B |
17.97% |
| 2019-03-31 |
$2.65B |
$0.46B |
17.20% |
| 2018-12-31 |
$2.60B |
$0.44B |
16.95% |
| 2018-09-30 |
$2.37B |
$0.43B |
18.09% |
| 2018-06-30 |
$2.16B |
$0.42B |
19.24% |
| 2018-03-31 |
$1.95B |
$0.41B |
20.97% |
| 2017-12-31 |
$1.76B |
$0.40B |
22.70% |
| 2017-09-30 |
$1.74B |
$0.39B |
22.61% |
| 2017-06-30 |
$1.72B |
$0.38B |
22.35% |
| 2017-03-31 |
$1.70B |
$0.38B |
22.38% |
| 2016-12-31 |
$1.67B |
$0.37B |
22.26% |
| 2016-09-30 |
$1.64B |
$0.36B |
22.14% |
| 2016-06-30 |
$1.61B |
$0.36B |
22.11% |
| 2016-03-31 |
$1.59B |
$0.35B |
22.04% |
| 2015-12-31 |
$1.58B |
$0.34B |
21.59% |
| 2015-09-30 |
$1.56B |
$0.32B |
20.17% |
| 2015-06-30 |
$1.56B |
$0.30B |
19.42% |
| 2015-03-31 |
$1.54B |
$0.28B |
18.22% |
| 2014-12-31 |
$1.50B |
$0.25B |
16.89% |
| 2014-09-30 |
$1.46B |
$0.23B |
15.70% |
| 2014-06-30 |
$1.41B |
$0.20B |
14.25% |
| 2014-03-31 |
$1.37B |
$0.18B |
13.29% |
| 2013-12-31 |
$1.44B |
$0.27B |
18.71% |
| 2013-09-30 |
$1.39B |
$0.26B |
18.45% |
| 2013-06-30 |
$1.34B |
$0.24B |
18.15% |
| 2013-03-31 |
$1.28B |
$0.23B |
17.86% |
| 2012-12-31 |
$1.21B |
$0.20B |
16.67% |
| 2012-09-30 |
$1.15B |
$0.19B |
16.45% |
| 2012-06-30 |
$1.10B |
$0.17B |
15.31% |
| 2012-03-31 |
$1.06B |
$0.17B |
15.66% |
| 2011-12-31 |
$1.02B |
$0.15B |
15.05% |
| 2011-09-30 |
$1.01B |
$0.26B |
25.49% |
| 2011-06-30 |
$1.00B |
$0.27B |
27.41% |
| 2011-03-31 |
$0.99B |
$0.28B |
28.57% |
| 2010-12-31 |
$0.99B |
$0.22B |
21.90% |
| 2010-09-30 |
$0.99B |
$0.14B |
13.69% |
| 2010-06-30 |
$0.98B |
$0.15B |
15.09% |
| 2010-03-31 |
$0.98B |
$0.15B |
15.46% |
| 2009-12-31 |
$0.89B |
$0.15B |
16.80% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Services |
$11.727B |
$8.282B |
|
ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide.
|
